The U.S. Food and Drug Administration (FDA) has issued draft guidance on its “Platform Technology Designation Program,” which aims to streamline drug development, manufacturing, and marketing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback